James “Jim” Sigg FDA's Deputy Commissioner for Operations and Chief Operating Officer | Official Website
James “Jim” Sigg FDA's Deputy Commissioner for Operations and Chief Operating Officer | Official Website
This is a 100% increase over the number of companies inspected in the previous month, when two companies received two inspections.
The companies inspected were involved in either the Biologics or Food and Cosmetics sectors.
There were three companies in line with FDA regulations who don’t need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct the organization's management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Emanuel Distributors | Food and Cosmetics | 01/13/2025 | Voluntary Action Indicated (VAI) |
| Fertility Center of Dallas | Biologics | 01/28/2025 | No Action Indicated (NAI) |
| Kevala International, LLC | Food and Cosmetics | 01/13/2025 | No Action Indicated (NAI) |
| Transplant Services Center UT Southwestern Medical Center | Biologics | 01/24/2025 | No Action Indicated (NAI) |
Alerts Sign-up